Development and validation of a panel of five proteins as blood biomarkers for early detection of colorectal cancer

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• ZorziMFedeliUSchievanoEImpact on colorectal cancer mortality of screening programmes based on the faecal immunochemical testGut201564578479025179811
   PubMed Web of Science ®Google Scholar
• BrennerHStockCHoffmeisterMEffect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studiesBMJ2014348g246724922745
   PubMed Web of Science ®Google Scholar
• ZauberAGWinawerSJO’BrienMJColonoscopic polypectomy and long-term prevention of colorectal-cancer deathsN Engl J Med2012366868769622356322
   PubMed Web of Science ®Google Scholar
• HewitsonPGlasziouPWatsonETowlerBIrwigLCochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an updateAm J Gastroenterol200810361541154918479499
   PubMed Web of Science ®Google Scholar
• BretthauerMKaminskiMFLobergMPopulation-based colonoscopy screening for colorectal cancer: a randomized clinical trialJAMA Intern Med2016176789490227214731
   PubMed Web of Science ®Google Scholar
• KlabundeCBlomJBulliardJLParticipation rates for organized colorectal cancer screening programmes: an international comparisonJ Med Screen201522311912625967088
   PubMed Web of Science ®Google Scholar
• AdlerAGeigerSKeilAImproving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in GermanyBMC Gastroenterol20141418325326034
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration [webpage on the Internet]Premarket Approval (PMA) for Epi proColonUS Food and Drug Administration2017 Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma.cfm?id=P130001Accessed September 15, 2017
   Google Scholar
• ChurchTRWandellMLofton-DayCProspective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancerGut201463231732523408352
   PubMed Web of Science ®Google Scholar
• ChenHWernerSTaoSZornigIBrennerHBlood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancerCancer Lett2014346217818724462820
   PubMed Web of Science ®Google Scholar
• LuoXBurwinkelBTaoSBrennerHMicroRNA signatures: novel biomarker for colorectal cancer?Cancer Epidemiol Biomarkers Prev20112071272128621551242
   PubMed Web of Science ®Google Scholar
• ChenHZucknickMWernerSKnebelPBrennerHHead-to-head comparison and evaluation of 92 plasma protein biomarkers for early detection of colorectal cancer in a true screening settingClin Cancer Res201521143318332626015516
   PubMed Web of Science ®Google Scholar
• BrennerHTaoSHaugULow-dose aspirin use and performance of immunochemical fecal occult blood testsJAMA2010304222513252021139112
   PubMed Web of Science ®Google Scholar
• HundtSHaugUBrennerHComparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detectionAnn Intern Med2009150316216919189905
   PubMed Web of Science ®Google Scholar
• PoxCPAltenhofenLBrennerHTheilmeierAVon StillfriedDSchmiegelWEfficacy of a nationwide screening colonoscopy program for colorectal cancerGastroenterology201214271460.e21467.e222446606
   PubMed Web of Science ®Google Scholar
• BrennerHAltenhofenLKretschmannJTrends in adenoma detection rates during the first 10 years of the German Screening Colonoscopy ProgramGastroenterology20151492356.e1366.e125911510
   PubMed Web of Science ®Google Scholar
• BrennerHAltenhofenLTaoSMatching of controls may lead to biased estimates of specificity in the evaluation of cancer screening testsJ Clin Epidemiol201366220220823257151
   PubMed Web of Science ®Google Scholar
• TaoSHaugUKuhnKBrennerHComparison and combination of blood-based inflammatory markers with faecal occult blood tests for non-invasive colorectal cancer screeningBr J Cancer201210681424143022454079
   PubMed Web of Science ®Google Scholar
• ChenHWernerSButtJProspective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening settingOncotarget2016713164201643226909861
   PubMedGoogle Scholar
• ZornigIHalamaNLorenzo BermejoJPrognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patientsInt J Cancer2015136113815124839182
   PubMed Web of Science ®Google Scholar
• WaterboerTSehrPMichaelKMMultiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteinsClin Chem200551101845185316099939
   PubMed Web of Science ®Google Scholar
• R Core Team [homepage on the Internet]R: A Language and Environment for Statistical ComputingVienna, AustriaR Foundation for Statistical Computing2014 Available from: http://www.R-project.org/Accessed September 15, 2017
   Google Scholar
• BootcovMRBauskinARValenzuelaSMMIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamilyProc Natl Acad Sci U S A1997942111514115199326641
   PubMed Web of Science ®Google Scholar
• SongMMehtaRSWuKPlasma inflammatory markers and risk of advanced colorectal adenoma in womenCancer Prev Res (Phila)201691273426511487
   PubMed Web of Science ®Google Scholar
• BrownDAHanceKWRogersCJSerum macrophage inhibitory cytokine-1 (MIC-1/GDF15): a potential screening tool for the prevention of colon cancer?Cancer Epidemiol Biomarkers Prev201221233734622144502
   PubMed Web of Science ®Google Scholar
• StaffACTrovikJErikssonAGElevated plasma growth differentiation factor-15 correlates with lymph node metastases and poor survival in endometrial cancerClin Cancer Res201117144825483321616994
   PubMed Web of Science ®Google Scholar
• BerasainCAvilaMAAmphiregulinSemin Cell Dev Biol201428314124463227
   PubMed Web of Science ®Google Scholar
• BusserBSanceyLBrambillaECollJLHurbinAThe multiple roles of amphiregulin in human cancerBiochim Biophys Acta20111816211913121658434
   PubMed Web of Science ®Google Scholar
• MehtaRSSongMBezawadaNA prospective study of macrophage inhibitory cytokine-1 (MIC-1/GDF15) and risk of colorectal cancerJ Natl Cancer Inst20141064dju01624565956
   PubMedGoogle Scholar
• WallinUGlimeliusBJirstromKGrowth differentiation factor 15: a prognostic marker for recurrence in colorectal cancerBr J Cancer2011104101619162721468045
   PubMed Web of Science ®Google Scholar
• SeligmannJFElliottFRichmanSDCombined epiregulin and amphiregulin expression levels as a predictive biomarker for panitumumab therapy benefit or lack of benefit in patients with RAS wild-type advanced colorectal cancerJAMA Oncol Epub2016211
   Web of Science ®Google Scholar
• YonesakaKTakegawaNSatohTCombined analysis of plasma amphiregulin and heregulin predicts response to cetuximab in metastatic colorectal cancerPLoS One20151011e014313226569500
   PubMed Web of Science ®Google Scholar
• WongSHKwongTNChowTCQuantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasiaGut20176681441144827797940
   PubMed Web of Science ®Google Scholar
• WuCWNgSCDongYIdentification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenomaClin Cancer Res201420112994300224691020
   PubMed Web of Science ®Google Scholar
• ChenHKnebelPBrennerHEmpirical evaluation demonstrated importance of validating biomarkers for early detection of cancer in screening settings to limit the number of false-positive findingsJ Clin Epidemiol20167510811426836253
   PubMed Web of Science ®Google Scholar
• BrennerHKloorMPoxCPColorectal cancerLancet201438399271490150224225001
   PubMed Web of Science ®Google Scholar
• VogelsteinBFearonERHamiltonSRGenetic alterations during colorectal-tumor developmentN Engl J Med198831995255322841597
   PubMed Web of Science ®Google Scholar
• MorsonBThe polyp-cancer sequence in the large bowelProc R Soc Med1974676 pt 14514574853754
   PubMedGoogle Scholar
• BrennerHAltenhofenLStockCHoffmeisterMNatural history of colorectal adenomas: birth cohort analysis among 3.6 million participants of screening colonoscopyCancer Epidemiol Biomarkers Prev20132261043105123632815
   PubMed Web of Science ®Google Scholar
• RhoJHLaddJJLiCIProtein and glycomic plasma markers for early detection of adenoma and colon cancerGut Epub2016117
   Web of Science ®Google Scholar
• LeeJKLilesEGBentSLevinTRCorleyDAAccuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysisAnn Intern Med2014160317124658694
   PubMed Web of Science ®Google Scholar
• TinmouthJLansdorp-VogelaarIAllisonJEFaecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to knowGut20156481327133726041750
   PubMed Web of Science ®Google Scholar
• RobertsonDJLeeJKBolandCRRecommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on Colorectal CancerGastroenterology201715251217.e31237.e327769517
   PubMed Web of Science ®Google Scholar
• ImperialeTFRansohoffDFItzkowitzSHMultitarget stool DNA testing for colorectal-cancer screeningN Engl J Med2014370141287129724645800
   PubMed Web of Science ®Google Scholar
• DickinsonBTKisielJAhlquistDAGradyWMMolecular markers for colorectal cancer screeningGut20156491485149425994221
   PubMed Web of Science ®Google Scholar